Skip to content

Development of an Imaging Prediction Model for Pelvic Lymph Node Metastasis of Cervical Cancer Using Artificial Intelligence Techniques.

Development of an Imaging Prediction Model for Pelvic Lymph Node Metastasis of Cervical Cancer Using Artificial Intelligence Techniques.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06448897
Enrollment
4000
Registered
2024-06-07
Start date
2024-02-01
Completion date
2025-12-31
Last updated
2024-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Artificial Intelligence, Cervical Cancer, Lymph Node Metastasis

Keywords

Cervical Cancer, Lymph Node Metastasis, Artificial Interlligence

Brief summary

This study is a retrospective exploratory trial conducted at a single center, aiming to develop and validate a preoperative lymphatic metastasis model for cervical cancer using artificial intelligence deep learning. The model is trained using preoperative imaging and postoperative pathological findings of cervical cancer patients, with the goal of enhancing the accuracy of lymphatic metastasis prediction through preoperative imaging and offering insights for treatment decisions.

Interventions

None listed

Sponsors

Obstetrics & Gynecology Hospital of Fudan University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. patients with preoperative diagnosis of invasive cervical cancer stage I-III, with any type of pathology, and patients who underwent radical/modified radical cervical cancer surgery + pelvic lymph node dissection in our hospital. 2. Age ≥18 years old and ≤80 years old 3. patients with complete preoperative pelvic MRI images and postoperative pathology and clinical data in our hospital

Exclusion criteria

1. Patients during pregnancy or breastfeeding, patients within 42 days of abortion 2. Patients who have received neoadjuvant chemotherapy or radiotherapy before surgery for this previous cervical cancer 3. Patients with other malignant tumors within 5 years 4. Combination of other underlying diseases that may lead to enlarged pelvic lymph nodes 5. Imaging report more than 1 month prior to surgery 6. Poor image quality and unrecognizable

Design outcomes

Primary

MeasureTime frameDescription
A model for identifying pelvic lymph node metastases on preoperative imagingFrom enrollment to the end of development of model at 24 monthsArtificial intelligence (AI) technology was utilized to develop a model for identifying pelvic lymph node metastasis from preoperative images in order to enhance the accuracy of preoperative lymph node metastasis detection in cervical cancer. The model was validated with the main diagnostic focus on determining the status of lymph node metastasis.

Countries

China

Contacts

Primary ContactXin Wu
wuxin_fc@fudan.edu.cn(021)33189900

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026